Last Updated: May 11, 2026

Claims for Patent: 12,370,189

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 12,370,189

Title:	Pharmaceutical formulation
Abstract:	The present invention is directed to a pharmaceutical composition comprising a pharmaceutically effective amount of guaifenesin, naproxen and at least one further active which is selected to be an antitussive, a decongestant or an antihistamine.
Inventor(s):	Raghu Cavatur, Kevin Chen, Matthew James Kaser, Hongchun Qiu
Assignee:	Reckitt Benckiser LLC , RB Health US LLC
Application Number:	US17/486,225
Patent Claims:	1. A pharmaceutical composition comprising: (a) about 600 mg of guaifenesin; (b) about 30 mg of dextromethorphan or a pharmaceutically acceptable salt thereof; (c) about 110 mg of naproxen or a pharmaceutically acceptable salt thereof; (d) at least 25 mg of hypromellose; and (e) at least 12.25 mg of hydroxyethyl cellulose; wherein the pharmaceutical composition provides a therapeutic effect in respect of each of guaifenesin, naproxen, and dextromethorphan for 12 hours, wherein the pharmaceutical composition is a bilayer tablet comprising an immediate release layer containing about 110 mg of the naproxen and at least 95 mg of the guaifenesin and at least 7.5 mg of the dextromethorphan, wherein the immediate release layer contains none of the hypromellose, and wherein the immediate release layer contains none of the hydroxyethyl cellulose. 2. The pharmaceutical composition of claim 1, further comprising sodium lauryl sulfate and sodium bicarbonate. 3. The pharmaceutical composition of claim 2, wherein the sodium bicarbonate is in an amount of about 60 mg. 4. The pharmaceutical composition of claim 3, wherein the immediate release layer contains all of the sodium lauryl sulfate and about 60 mg of the sodium bicarbonate. 5. A pharmaceutical composition comprising: (a) about 600 mg of guaifenesin; (b) about 30 mg of dextromethorphan or a pharmaceutically acceptable salt thereof; (c) about 110 mg of naproxen or a pharmaceutically acceptable salt thereof; (d) sodium lauryl sulfate; and (e) about 60 mg of sodium bicarbonate; wherein the pharmaceutical composition provides a therapeutic effect in respect of each of guaifenesin, naproxen, and dextromethorphan for 12 hours, wherein the pharmaceutical composition is a bilayer tablet comprising an immediate release layer containing about 110 mg of the naproxen and at least 95 mg of the guaifenesin and at least 7.5 mg of the dextromethorphan, wherein the immediate release layer contains all of the sodium lauryl sulfate and about 60 mg of the sodium bicarbonate. 6. The pharmaceutical composition of claim 5, further comprising 1-8% hypromellose by weight of the total composition and 1-3% hydroxyethyl cellulose by weight of the total composition. 7. The pharmaceutical composition of claim 6, wherein the hypromellose is in an amount of at least 25 mg and the hydroxyethyl cellulose is in an amount of at least 12.25 mg. 8. The pharmaceutical composition of claim 7, wherein the immediate release layer contains none of the hypromellose, and wherein the immediate release layer contains none of the hydroxyethyl cellulose.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.